The e-commerce firm overhauls its logo and website, adding additional content and products to its inventory of more than 34,000 SKUs, bulking up in categories outside of traditional supplements, including conventional food, personal care and beauty products.

The e-commerce firm overhauls its logo and website, adding additional content and products to its inventory of more than 34,000 SKUs, bulking up in categories outside of traditional supplements, including conventional food, personal care and beauty products.

Pfizer is discounting its blockbuster brand Lipitor more aggressively. But, thanks to the economics of Medicare Part D, the product is still benefiting from a big net price increase in 2006. Lipitor's performance is some much needed good news for Pfizer--and maybe even better news for the industry as a whole.

With the free-fall in dot com stocks, money has flowed--with a vengeance--into biotech. But the valuations are not sustainable: most of the new companies are shooting for a market far too small to support even half of the new competitors, and trying to sell only portions of what drug companies want to buy.